$NDRA ENDRA Life Sciences Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ENDRA Life Sciences Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ENDRA Life Sciences Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in ENDRA Life Sciences Inc. for free.

CIK Number: 0001681682
IRS Number: 260579295
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Trading Symbol: NDRA
Company Address: 3600 GREEN COURT SUITE 350 ANN ARBOR 48105
Phone number: 734-335-0468
Former name: Endra Inc., date of change: 2016-08-05

ENDRA Life Sciences, Inc. engages in the development of ultrasound technology for the pre-clinical research market. Its products include Photo-Acoustic Nexus-128 system, which screens and modifies disease models, and Thermo-Acoustic Enhanced UltraSound, which will enable clinicians to visualize human tissue composition, function, and temperature. The company was founded in 2007 and is headquartered in Ann Arbor, MI.

ENDRA Life Sciences Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
DIGIANDOMENICO ANTHONYDirector118,1490shares bought: 78,950 / shares sold: 0 STRONG BUYNov 15 201827 days ago
Longboard Capital Advisors, LLC10% Owner379,2370shares bought: 0 / shares sold: -260,400 STRONG SELLOct 24 20182 months ago
Michelon Francois RogerChief Executive Officer32,4970shares bought: 32,497 / shares sold: 0 STRONG BUYNov 15 201827 days ago
Thornton Michael MilosChief Technology Officer89,7500shares bought: 84,782 / shares sold: 0 STRONG BUYNov 15 201827 days ago
Wells David R.Chief Financial Officer24,7860shares bought: 24,786 / shares sold: 0 STRONG BUYNov 15 201827 days ago

View all ENDRA Life Sciences Inc. insiders.

ENDRA Life Sciences Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 15 2018NDRAENDRA Life Science ...Wells David R.Chief Financial Off ...BuyC1.685,95310,00124,78618.8 K to 24.8 K (+31.61 %)
Nov 15 2018NDRAENDRA Life Science ...Thornton Michael MilosChief Technology Of ...BuyC1.6829,76250,00089,75060 K to 89.8 K (+49.61 %)
Nov 15 2018NDRAENDRA Life Science ...Michelon Francois RogerChief Executive Off ...BuyC1.685,95310,00132,49726.5 K to 32.5 K (+22.43 %)
Nov 15 2018NDRAENDRA Life Science ...DIGIANDOMENICO ANTHONYDirectorBuyC1.6859,524100,000118,14958.6 K to 118.1 K (+101.53 %)
Oct 24 2018NDRAENDRA Life Science ...Longboard Capital Advisors, LL ...10% OwnerSellS4.1830,000125,283299,237329.2 K to 299.2 K (-9.11 %)
Oct 24 2018NDRAENDRA Life Science ...Longboard Capital Advisors, LL ...10% OwnerSellS4.1830,000125,283299,237329.2 K to 299.2 K (-9.11 %)
Oct 24 2018NDRAENDRA Life Science ...Longboard Capital Advisors, LL ...10% OwnerSellS4.2250,000210,885329,237379.2 K to 329.2 K (-13.18 %)
Oct 24 2018NDRAENDRA Life Science ...Longboard Capital Advisors, LL ...10% OwnerSellS4.2250,000210,885329,237379.2 K to 329.2 K (-13.18 %)
Oct 24 2018NDRAENDRA Life Science ...Longboard Capital Advisors, LL ...10% OwnerSellS4.1650,200209,078379,237429.4 K to 379.2 K (-11.69 %)
Oct 24 2018NDRAENDRA Life Science ...Longboard Capital Advisors, LL ...10% OwnerSellS4.1650,200209,078379,237429.4 K to 379.2 K (-11.69 %)
Jul 02 2018NDRAENDRA Life Science ...DIGIANDOMENICO ANTHONYDirectorOption ExerciseA2.5224,80262,50124,802
Jul 02 2018NDRAENDRA Life Science ...DIGIANDOMENICO ANTHONYDirectorOption ExerciseA2.5224,80262,50124,802
Jul 02 2018NDRAENDRA Life Science ...Wells David R.Chief Financial Off ...Option ExerciseA2.522,4806,2502,480
Jul 02 2018NDRAENDRA Life Science ...Wells David R.Chief Financial Off ...Option ExerciseA2.522,4806,2502,480
Jul 02 2018NDRAENDRA Life Science ...Thornton Michael MilosChief Technology Of ...Option ExerciseA2.5212,40131,25112,401

View all ENDRA Life Sciences Inc. insider transactions.